Skip to content

Distal Venous Arterialisation of Ischemic Limb

Distal Venous Arterialisation in the Treatment of Critical Ischemia of Lower Limb

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01211925
Enrollment
30
Registered
2010-09-30
Start date
2009-09-30
Completion date
2011-07-31
Last updated
2010-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Limb Ischemia

Keywords

unreconstructable peripheral arterial disease

Brief summary

Distal venous arterialisation (DVA) improve outcome in patients with nonreconstructible peripheral arterial occlusive disease.

Detailed description

The aim of this study was to estimate validity of distal venous arterialisation (DVA) as a limb salvage procedure. This prospective randomized study reported early results of 30 unreconstructible patients with critical limb ischemia (CLI) treated during 2009 year at Clinic for vascular surgery, Clinical Center of Serbia in Belgrade. Patients were divided in two groups, 10 treated with DVA and 20 conservatively (CT) using antiplatelet drugs.

Interventions

PROCEDUREdistal venous arterialisation

The investigators perform reverse revascularisation of the ischemic limb with arterial blood supply from patent in flow artery to the superficial dorsal venous arch.

DRUGAspirin

100 mg per day continuous

Sponsors

University of California, Los Angeles
CollaboratorOTHER
Clinical Centre of Serbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Absence of any possibility for direct revascularisation due to extensive occlusive disease of crural and pedal arteries * Sufficient deep venous system and usable great saphenous vein as a graft for in situ bypass surgery according duplex scanning * localized infective of necrotic process up to the metatarsal level * Satisfactory general patient condition

Exclusion criteria

* advanced lower limb ischemia * venous insufficiency of lower limb

Design outcomes

Primary

MeasureTime frameDescription
limb salvage1 yearThe investigators will estimate clinical improvement in patients with critical limb ischemia underwent of distal venous arterialisation. Comparative group consist patients treated with antiplatelet drugs.

Secondary

MeasureTime frameDescription
lactate level in the blood of deep venous system1 yearThe investigators measure metabolic changes in the patients after distal venous arterialisation

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026